您的位置: 首页 > 农业专利 > 详情页

New oxyntomodulin derivatives and pharmaceutical compositions for the treatment of obesity comprising these
专利权人:
Ltd.;Hanmi Science Co.
发明人:
JUNG, Sung Youb,JANG, Myung Hyun,SHEN, Ling Ai,PARK, Young Kyung,PARK, Young Jin,KWON, Se Chang
申请号:
DK12797363
公开号:
DK2718318T3
申请日:
2012.06.07
申请国别(地区):
DK
年份:
2018
代理人:
摘要:
The present invention relates to a novel peptide showing more excellent activities on a glucagon like peptide-1 receptor and a glucagon receptor than native oxyntomodulin, and a composition for the prevention or treatment of obesity comprising the peptide as an active ingredient. Unlike native oxyntomodulin, the novel peptide of the present invention reduces food intake, suppresses gastric emptying, and facilitates lipolysis with reduced side-effects, and also shows excellent receptor-activating effects. Thus, it can be widely used in the treatment of obesity with safety and efficacy.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充